JNJ

Johnson & Johnson cuts bonuses for new CEO, other execs by 10 percent due to 'disappointments'

Johnson & Johnson cuts bonuses for new CEO, other execs by 10 percent due to 'disappointments'

Yahoo/AP

Overseas Tax Savings for U.S. Drugmakers Under Threat

Overseas Tax Savings for U.S. Drugmakers Under Threat

Bloomberg

J&J Seeks EU Nod for Combo Drug

J&J Seeks EU Nod for Combo Drug

Yahoo/Zacks

J&J Faces Second Trial Over Recalled Hip After Loss

J&J Faces Second Trial Over Recalled Hip After Loss

Bloomberg

The Best Choice in Healthcare, Period

The Best Choice in Healthcare, Period

Motley Fool

JNJ

4 Pharmaceutical Stocks to Buy Now

4 Pharmaceutical Stocks to Buy Now

InvestorPlace

Hip Defect Could Cost Johnson & Johnson Billions

Hip Defect Could Cost Johnson & Johnson Billions

Wall Street Cheat Street

Johnson & Johnson Could Tap The Huge Diabetes Market With New Drug Approval

Johnson & Johnson Could Tap The Huge Diabetes Market With New Drug Approval

Seeking Alpha

Johnson & Johnson Could Tap The Huge Diabetes Market With New Drug Approval

Johnson & Johnson Could Tap The Huge Diabetes Market With New Drug Approval

Forbes

Pharmaceutical Winners And Losers In Early 2013

Pharmaceutical Winners And Losers In Early 2013

Motley Fool